Dave A. Chokshi, MD, MSc, FACP, is a primary care internist at Bellevue Hospital and Clinical Associate Professor of Population Health and Medicine at the NYU School of Medicine. From 2014 to 2020, he served in leadership roles at NYC Health + Hospitals, the largest public health care system in the nation, including as its inaugural Chief Population Health Officer and CEO of the H+H Accountable Care Organization. Dr. Chokshi built and grew an award-winning team dedicated to health system improvement, spanning innovative care models and analytics, primary care transformation, social determinants of health, community-based care management, chronic diseases and prevention, and value-based payment.
Previously, Dr. Chokshi served as a White House Fellow and was the principal health advisor to the Secretary of Veterans Affairs. His prior work experience spans the public, private, and nonprofit sectors, including positions with the New York City and State Departments of Health, the Louisiana Department of Health, a startup clinical software company, and the global nonprofit Universities Allied for Essential Medicines (UAEM).
Dr. Chokshi has written widely on medicine and public health including in The New England Journal of Medicine, where he serves on the editorial board of NEJM Catalyst, and JAMA, where he contributes to the JAMA Forum. He serves on the Board of Directors for the Primary Care Development Corporation and as Chair of the Clinical Advisory Council for RubiconMD, a health technology company. In 2016, President Obama appointed him to the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health.
He trained in internal medicine at Brigham & Women's Hospital, where he received the Dunne Award for Compassionate Care, and was a clinical fellow at Harvard Medical School. During his training, Dr. Chokshi did clinical work in Guatemala, Peru, Botswana, Ghana, and India. He received his M.D. with Alpha Omega Alpha distinction from Penn, where he was elected by his peers to win the Joel Gordon Miller Prize. He also earned an MSc in global public health as a Rhodes Scholar at Oxford, and graduated summa cum laude from Duke.
